Data compiled by Redley Lamar · ChainSifter Intelligence
3Suppliers
1Customers
2Debt Items
0Related Chains
Source-Backed Evidence Depth
Nuvectis Pharma, Inc. (NVCT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
7Total relationships
2Distinct source URLs
6High confidence
0.866Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Nuvectis Pharma, Inc. Suppliers
Ticker
Name
Confidence
Evidence
SINGLE-SOLE-SOURCE-MANUFACTURER
SINGLE-SOLE-SOURCE-MANUFACTURER
92%
a single, sole source manufacturer to make the NXP900 drug substance and another single, sole source manufacturer to make the NXP900 finished drug product
UNIVERSITY-OF-EDINBURGH
UNIVERSITY-OF-EDINBURGH
92%
In August 2021, the Company entered into a worldwide, exclusive license agreement with the University of Edinburgh, Scotland for the Company's drug candidate NXP900
CRT-PIONEER-FUND
CRT-PIONEER-FUND
90%
There have been no material changes to the CRT Pioneer Fund License Agreement, as previously disclosed in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025
Nuvectis Pharma, Inc. Customers
Ticker
Name
Confidence
Evidence
DELAWARE-GENERAL-CORPORATION
DELAWARE-GENERAL-CORPORATION
62%
our bylaws and Delaware law may deter unsolicited takeovers and/or delay or prevent a change in control of our Company, including transactions in which our stockholders might otherwise receive a prem…
Nuvectis Pharma, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
NVCT-DEBT-11426
Warrants outstanding: 11192000
90%
xbrl warrant detail from xbrl 2023-12-31.
NVCT-DEBT-11427
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2022-12-31.
Nuvectis Pharma, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Nuvectis Pharma, Inc..
Nuvectis Pharma, Inc. Ownership
Holder
Name
Confidence
Evidence
NVCT-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC
VANGUARD CAPITAL MANAGEMENT LLC
90%
13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 63 tracked holders.
Nuvectis Pharma, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
